- Name: Zhi-Ming Li
- Title: Professor, Chief Physician
- Email: lizhm@sysucc.org.cn
- Phone:
Clinical and translational research for lymphoma, head and neck cancer (including nasopharyngeal cancer). Especially development of novel drugs, prognostic and predictive markers for these tumors, conduct of phase I and II clinical trials to test drugs.
Bachelor of Medicine, Sun Yat-Sen University of Medical Sciences, China, 1992-1997
Ph.D. in Oncology, Sun Yat-sen University, China, 1997-2002
Post Doctorate, Sun Yat-sen University Cancer Center, China, 2002-2004
Visiting scholar, Oncology Institute of Southern Switzerland, Switzerland, 2011-2012
Selected publications
1. Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non-Hodgkin lymphoma. Wu K, Sun XQ, Wang CQ, Gao TX, Sun P, Wang Y, Jiang WQ, Li ZM#, Huang JJ#. Cancer Med 2020
2. High-dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China. Chen C, Sun P, Cui J, Yan SM, Chen H, Xia Y, Bi XW, Liu PP, Wang Y, Yang H, Nie M, Zhang XW, Jiang WQ, Li ZM#. Cancer Med 2019
3. Mutation Profiling of Malignant Lymphoma by Next-Generation Sequencing of Circulating Cell-Free DNA. Sun P*, Chen C*, Xia Y*, Wang Y, Liu PP, Bi XW, Shao YW, Ou QX, Wu X, Yang H, Nie M, Zhang XW, Li ZM#, Jiang WQ#. Journal of Cancer 2019
4. Trends in Survival of Patients With Primary Gastric Diffuse Large B-Cell Lymphoma: An Analysis of 7051 Cases in the SEER Database. Liu PP, Xia Y, Bi XW, Wang Y, Sun P, Yang H, Li ZM#, Jiang WQ#. Dis Markers 2018
5. A Comparison of R-EPOCH and R-CHOP as a First-Line Regimen in De Novo DLBCL Patients With High Ki-67 Expression in a Single Institution. Huang JJ, Xia Y, Wang Y, Liu PP, Bi XW, Sun P, Lin TY, Jiang WQ, Li ZM#. Oncotarget, 2016
6. Racial Patterns of Patients With Primary Mediastinal Large B-cell Lymphoma: SEER Analysis. Liu PP*, Wang KF*, Xia Y, Bi XW, Sun P, Wang Y, Li ZM#, Jiang WQ#. Medicine (Baltimore) 2016
7. High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma. Zhang X*, Huang JJ*, Xia Y*, Li CF, Wang Y, Liu PP, Bi XW, Sun P, Lin TY, Jiang WQ, Li ZM#. Oncotarget, 2016
8. Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma. Nie M*, Bi XW*, Zhang WW*, Sun P, Xia Y, Liu PP, Huang HQ, Jiang WQ, Li ZM#. Sci Rep 2016
9. Effect of Rituximab on Adult Burkitt's Lymphoma: A Systematic Review and Meta-Analysis. Nie M*, Wang Y*, Bi XW, Xia Y, Sun P, Liu PP, Li ZM#, Jiang WQ#. Ann Hematol 2016
10. Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt’s lymphoma. Wei WX*, Huang JJ*, Li WY, Zhang X, Xia Y, Jiang WQ, Fan W#, Li ZM#. Chin J Cancer 2015
11. Expression of BAFF-R, but Not BAFF, Is an Independent Prognostic Factor in Diffuse Large B-cell Lymphoma Patients Treated With R-CHOP. Wang Y*, Li YJ*, Jiang WQ, Rao HL, Huang JJ, Xia Y, Bi XW, Sun P, Huang HQ, Lin TY, Guan ZZ, Li ZM#. Ann Hematol, 2015
12. Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma. Bi XW*, Xia Y*, Zhang WW, Sun P, Liu PP, Wang Y, Huang JJ, Jiang WQ, Li ZM#. Ann Hematol 2015
13. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis. Song CG*, Huang JJ*, Li YJ*, Xia Y, Wang Y, Bi XW, Jiang WQ, Huang HQ, Lin TY, Li ZM#. PLoS One 2015
14. Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy. Bi XW*, Jiang WQ*, Zhang WW, Huang JJ, Xia Y, Wang Y, Sun P, Li ZM#. Ann Hematol 2015
15. High APRIL but not BAFF serum levels are associated with poor outcome in patients with follicular lymphoma. Li YJ*, Li ZM*, Xia ZJ, Li S, Xia Y, Huang HQ, Huang JJ, Yi PY#, Jiang WQ#. Ann Hematol 2015
16. Prognostic Value of Interim and Posttherapy 18F-FDG PET/CT in Patients with Mature T-Cell and Natural Killer Cell Lymphomas. Ya-Jun Li*, Li ZM*, Xi-Ya Xia*, Huang HQ, Xia ZJ, Lin TY, Li S, Xia Y, Cai XY, Jiang WQ#. J Nucl Med 2013
17. Absolute Lymphocyte Count Is a Novel Prognostic Indicator in Extranodal Natural killer/T-cell Lymphoma, Nasal Type. Huang JJ*, Jiang WQ*, Lin TY, Huang Y, Xu RH, Huang HQ, Li ZM#. Ann Oncol 2011
18. Beclin 1 expression: A predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type. Huang JJ, Li HR, Huang Y, Jiang WQ, Xu RH, Huang HQ, Lv Y, Xia ZJ, Zhu XF, Lin TY#, Li ZM#. Autophagy 2010
Updated May 2020 by International Office, Sun Yat-sen University Cancer Center